ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 128 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 162 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 162 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -85.7% | 162 | -86.1% | 0.00% | -100.0% |
| Q3 2017 | $7,000 | +600.0% | 1,162 | +617.3% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 162 | -20.2% | 0.00% | – |
| Q3 2016 | $1,000 | – | 203 | +395.1% | 0.00% | – |
| Q2 2016 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |